Washington, September 27 (IANS): The world will return to normal life as Covid-19 will end in a year, Pfizer CEO Albert Bourla has said, while stressing the need for annual Covid jabs.
"Within a year I
Washington, September 27 (IANS): The world will return to normal life as Covid-19 will end in a year, Pfizer CEO Albert Bourla has said, while stressing the need for annual Covid jabs.
"Within a year I
Washington, September 10 (IANS): US drug maker Moderna has announced the development of a single-dose vaccine candidate that is a combination of a Covid-19 booster as well as a seasonal flu jab.
"We bel
New York, January 25 (IANS): US-based drugmaker Moderna on Monday said its Covid-19 vaccine retains neutralising activity against emerging variants first identified in the UK and South Africa.
Vaccination wi
New York Decèmber 4 (IANS): US-based drugmaker Moderna has said that it expects to have between 100 million and 125 million doses of its experimental Covid-19 vaccine available globally in the first quar
Reuters
Drugmakers and research centres around the world are working on COVID-19 vaccines, with large global trials of several of the candidates involving tens of thousands of participants well underway.
Berlin, November 23 (IANS): Governments seeking to purchase Moderna's potential Covid-19 vaccine may have to shell out $25 and $37 per dose, depending on the size of the order, the company's CEO Stephan
Moscow, November 22 (IANS): Russia's Sputnik V vaccine against Covid-19 will cost governments much lower than that of Pfizer's and Moderna's, the official Twitter handle of the world's firs